登录
注册
您所在的位置:首页>>报告>>报告详情

Tetanus vaccines: WHO position paper – February 2017

破伤风疫苗:世卫组织立场文件——2017年2月

【作       者】:

{{d.作者}}

【机       构】: 世界卫生组织
【承研机构】:

【原文地址】: https://www.who.int/publications/i/item/tetanus-vaccines-who-position-paper-february-2017
【发表时间】:

2020-01-10

摘要

In accordance with its mandate to provideguidance to Member States on healthpolicy matters, WHO issues a series ofregularly updated position papers onvaccines and combinations of vaccinesagainst diseases that have an internationalpublic health impact. These papers areconcerned primarily with the use ofvaccines in large-scale immunizationprogrammes. They summarize essentialbackground information on diseases andvaccines and conclude with the currentWHO position on the use of vaccinesworldwide. The papers are reviewed by externalexperts and WHO staff, and reviewed andendorsed by the WHO Strategic AdvisoryGroup of Experts on Immunization(SAGE) ( ). The GRADE methodologyis used to systematically assess the quality of the available evidence. The SAGEdecision-making process is reflected inthe evidence-to-recommendation table.1A description of the processes followedfor the development of vaccine positionpapers is available at: The position papers are intended for usemainly by national public health officialsand managers of immunizationprogrammes. They may also be of interestto international funding agencies, vaccineadvisory groups, vaccine manufacturers,the medical community, the scientificmedia, and the general public.

标签: {{b}}
展开